Primary end points of clinical trials - overall survival versus progression free survival.

New agent eribulin prolongs survival in metastatic breast cancer

Current techniques in the treatment of lung cancer

Results of the multiple myeloma study comparing zoledronic acid to clodronate

Using oncopolicy to tackle issue of ageism in cancer treatment

Tackling ageism in cancer treatment

The role of patient advocacy groups and the efforts being made to help improve the spread and accessibility of information for patients

The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases

NKTR-102: a new drug for treating platinum-resistant or refractory ovarian cancer

Progress in myeloma survival rates

Conatumumab or AMG 479 as treatment for pancreatic cancer

Roundup of the 2010 ASCO conference